Numbers of subjects from polluted and background area with increasing number of multiple adverse signs in quintiles of PCB level | ||||||||
---|---|---|---|---|---|---|---|---|
Area | Quintile of PCB level | Numbers of multiple adverse signs | Range of serum PCB level (ng/g lipid) | |||||
0–1 | 2–3 | 4–5 | 6–7 | 8–9 | 10–11 | |||
POLLUTED | 1 | 32 | 69 | 62 | 29 | 8 | 1 | 337 – 1136 |
2 | 26 | 66 | 61 | 32 | 13 | 3 | 1136 – 1619 | |
3 | 25 | 57 | 61 | 45 | 12 | 2 | 1670 – 2279 | |
4 | 19 | 74 | 60 | 38 | 19 | 1 | 2290 – 3395 | |
5 | 23 | 62 | 55 | 51 | 11 | ---- | 3616 – 101,413 | |
TOT = 1008 | 125 | 328 | 299 | 195 | 54 | 7 | ||
BACKGROUND | 1 | 68 | 76 | 50 | 10 | 3 | ---- | 149 – 521 |
2 | 55 | 70 | 60 | 19 | 3 | ---- | 523 – 661 | |
3 | 57 | 77 | 47 | 19 | 8 | ---- | 661 – 825 | |
4 | 42 | 79 | 61 | 20 | 6 | ---- | 826 – 1072 | |
5 | 50 | 85 | 55 | 16 | 2 | ---- | 1075 – 16,391 | |
TOT = 1038 | 272 | 387 | 273 | 84 | 22 | ---- |